Parag Shah's most recent trade in Bellerophon Therapeutics Inc was a trade of 50,000 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics Inc | Parag Shah | VP of Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 50,000 | 50,000 | - | - | Stock Options (Right to Buy) | |
| Bellerophon Therapeutics Inc | Parag Shah | VP OF BUSINESS OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 50,000 | 50,000 | - | - | Stock Options (right to buy) | |
| Bellerophon Therapeutics Inc | Parag Shah | VP OF BUSINESS OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 25,500 | 25,500 | - | - | Restricted Stock Units | |
| Bellerophon Therapeutics Inc | Parag Shah | VP OF BUSINESS OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 25,500 | 25,500 (0%) | 0% | - | Common Stock | |
| Bellerophon Therapeutics Inc | Parag Shah | VP OF BUSINESS OPERATIONS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 09 Dec 2022 | 7,834 | 17,666 (0%) | 0% | 0.9 | 7,286 | Common Stock |
| Bellerophon Therapeutics Inc | Parag Shah | VP OF BUSINESS OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 51,000 | 51,000 | - | - | Restricted Stock Units |